The mask of acute bacterial pneumonia may disguise the face of tuberculosis

Authors

  • Fereshte Sheybani Assistant Professor in Infectious Diseases, Department of Infectious Diseases and Tropical Medicine, Imam Reza Teaching Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Keywords:

Pneumonia, Tuberculosis, Community-Acquired Pneumonia

Abstract

Introduction: Pulmonary tuberculosis (TB) can present as acute pneumonia. Differentiation of tuberculous from non-tuberculous community-acquired pneumonia (CAP) is an important challenge in endemic areas. The purpose of this study was the comparison between characteristics of tuberculous and non-tuberculous CAP patients.

Methods: In this prospective and observational study, all adult patients (aged ≥16 years) who were admitted to Imam Reza Hospital in Mashhad (Iran) with the diagnosis of CAP, between February 2013 and January 2014, were enrolled. Clinical, radiological, and microbiological data of the patients were collected and reviewed. Statistical analyses were performed using SPSS 14 software and R programming language.

Results: We studied 120 patients with diagnosis of acute CAP including 21 (17.5%) tuberculous and 99 (82.5%) non-tuberculous CAP. The etiologies of CAP in the latter group were as follow: S. pneumoniae 29 (29.3%), followed by S. aureus, polymicrobial including anaerobes, and other agents. The diagnosis of pneumonia remained unknown in 49 (40%) patients. We found approximately equal gender distribution among two study groups (14/21 vs. 61/99, 63.6% vs. 62.9%, p=0.948). Fifty percent of patients with tuberculous CAP had opioid addiction that was more frequent compared with non-tuberculous group (p=0.240). 52.4%, 63.2%, 30%, and 90% of patients with tuberculous CAP had severe presentation based on PSI, IDSA/ATS, CURB-65, and SMART-COP, respectively. 

Conclusions: The diagnosis of TB should be considered in all patients who presented with CAP in endemic regions.  It could not be differentiated from other causes of pneumonia on clinical and radiological grounds.

References

Azizi MH, Bahadori M. A brief history of tuberculosis in Iran during the 19th and 20th centuries. Arch Iran

Med. 2011; 14(3): 215-9. doi: 011143/AIM.0018. PMID: 21529117.

WHO Global Tuberculosis report 2015. Available from: http://www.who.int/tb/country/data/profiles/en/.

Alavi SM, Salmanzadeh Sh, Bakhtiyariniya P, Albagi A, Hemmatnia F, Alavi L. Prevalence and treatment

outcome of pulmonary and extrapulmonary pediatric tuberculosis in southwestern Iran. Caspian J Intern

Med. 2015; 6(4): 213–9. PMID: 26644895, PMCID: PMC4649270.

Lotfian F, Bolursaz MR, Khalilzadeh S, Baghaie N, Hassanzad M, Velayati AA. Features of Adolescents

Tuberculosis at a Referral TB’s Hospital in Tehran, Iran. Mediterr J Hematol Infect Dis. 2016; 8(1):

e2016005. doi: 10.4084/MJHID.2016.005. PMID: 26740866, PMCID: PMC4696473.

Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Kinh NV, et al. The bacterial aetiology of adult

community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014; 108(6):

-37. doi: 10.1093/trstmh/tru058. PMID: 24781376, PMCID: PMC4023908.

Schlossberg D. Acute tuberculosis. Infect Dis Clin North Am. 2010; 24(1): 139-46. doi:

1016/j.idc.2009.10.009. PMID: 20171549.

Ministry of Public Health and Education of Iran. Tuberculosis Situation In Iran. 2013. Available from:

http://tb-lep.behdasht.gov.ir/TB_Situation_in_Iran.aspx.

Naderi H, Sheybani F, Sarvghad M, Meshkat Z, Nooghabi MJ. Etiological Diagnosis of Community- Acquired Pneumonia in Adult Patients: A Prospective Hospital-Based Study in Mashhad, Iran. Jundishapur

J Microbiol. 2015; 8(8). doi: 10.5812/jjm.22780. PMID: 26464771, PMCID: PMC4600341.

Wasan A, Butler SF, Budman SH, Fernandez K, Weiss R, Greenfield Sh. et al. Does Report of Craving

Opioid Medication Predict Aberrant Drug Behavior Among Chronic Pain Patients? Clin J Pain. 2009;

(3): 193–198. doi: 10.1097/AJP.0b013e318193a6c4. PMID: 19333168, PMCID: PMC2664529.

Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR. Empiric treatment of community-acquired

pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis. 2002;

(12): 1607-12. PMID: 12032896.

Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized

community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the

United States. Am J Respir Criti Care Med. 2002; 165(6):766-72. doi: 10.1164/ajrccm.165.6.2103038.

PMID: 11897642.

Gatey C, Tattevin P, Rioux C, Ducot B, Meyer L, Bouvet E. Impact of early chest radiography and

empirical antibiotherapy on delay in the diagnosis of pulmonary tuberculosis. Med Mal Infect. 2012; 42(3):

-3. doi: 10.1016/j.medmal.2011.12.003. PMID: 22398329.

Nyamande K, Lalloo UG, John M. TB presenting as community-acquired pneumonia in a setting of high

TB incidence and high HIV prevalence. Int J Tuberc Lung Dis. 2007; 11(12): 1308-13. PMID: 18034951.

Asnis DS, Cherian S, Sun T, Shrestha S, Santucci T. Pulmonary tuberculosis presenting as community- acquired pneumonia. Clin Infect Dis. 2002; 35(12): 1574-1575. PMID: 12471584.

Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, et al. Aetiology, outcome, and risk factors for

mortality among adults with acute pneumonia in Kenya. Lancet. 2000; 355(9211): 1225-30. PMID:

16) Lévy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Importance of initial

noninvasive bacteriologic and radiographic investigations. Chest. 1988; 93(1): 43-8. PMID: 3275531.

Liam CK, Pang YK, Poosparajah S. Pulmonary tuberculosis presenting ascommunity-acquired pneumonia.

Respirology. 2006; 11(6): 786-92. doi: 10.1111/j.1440-1843.2006.00947.x. PMID: 17052309.

Kunimoto D, Long R. Tuberculosis: still overlooked as a cause of community-acquired pneumonia--how

not to miss it. Respir Care Clin N Am. 2005; 11(1): 25-34. doi: 10.1016/j.rcc.2004.10.007. PMID: 15763219.

Naderi M, Hashemi M, Kouhpayeh H, Ahmadi R. The status of serum procalcitonin in pulmonary

tuberculosis and nontuberculosis pulmonary disease. J Pak Med Assoc. 2009; 59(9): 647-648. PMID:

Ugajin M, Miwa S, Shirai M, Ohba H, Eifuku T, Nakamura H, et al. Usefulness of serum procalcitonin

levels in pulmonary tuberculosis. Eur Respir J. 2011; 37(2): 371-5. doi: 10.1183/09031936.00011910.

PMID: 20530033.

Rasmussen TA, Søgaard OS, Camara C, Andersen PL, Wejse C. Serum procalcitonin in pulmonary

tuberculosis. Int J Tuberc Lung Dis. 2011; 15(2): 251-6. PMID: 21219690.

Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in

differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med. 2009;

(4): 337-42. doi: 10.3904/kjim.2009.24.4.337. PMID: 19949732, PMCID: PMC2784977.

Levy H, Kallenbach JM, Feldman C, Thorburn JR, Abramowitz JA. Acute respiratory failure in active

tuberculosis. Crit Care Med. 1987; 15(3): 221-5. PMID: 3469061.

Feng JY, Fang WF, Wu CL, Yu CJ, Lin MC, Ku SC, et al. Concomitant pulmonary tuberculosis in

hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective

study. PLoS One. 2012; 7(5): e36832. doi: 10.1371/journal.pone.0036832. PMID: 22629334, PMCID:

PMC3358294.

Published

2022-01-18

Issue

Section

Articles